Review: 'Through the Shadowlands’ describes Julie Rehmeyer's ME/CFS Odyssey
I should note at the outset that this review is based on an audio version of the galleys and the epilogue from the finished work. Julie Rehmeyer sent me the final version as a PDF, but for some reason my text to voice software (Kurzweil) had issues with it. I understand that it is...
Discuss the article on the Forums.

University of Florida Phase 3 Trial on CoQ10, for kids 12 to 17

Discussion in 'Active Clinical Studies' started by *GG*, Oct 20, 2010.

  1. *GG*

    *GG* senior member

    Messages:
    6,220
    Likes:
    4,854
    Concord, NH
    The University of Florida is continuing to recruit patients for a clinical trial to investigate the safety and effectiveness of Coenzyme Q10 (CoQ10) as a treatment for children with specific mitochondrial diseases.

    CoQ10 is a mitochondrial cofactor and antioxidant in the process that cells use to convert food and oxygen into energy.

    To be considered for the trial, patients must be 12 months to 17 years of age and have a biochemical or molecular diagnosis of a deficiency of complex I, III or IV of the respiratory chain.

    For additional information contact Courtney Yates, RN, at Courtney.Yates@medicine.ufl.edu or at 352-273-9016.
     

See more popular forum discussions.

Share This Page